PBH
NYSE Prestige Consumer Healthcare Inc$49.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $49.00, $0.41 below the day’s high of $49.41
- YTD change
- -20.57%
- vs 20-day SMA
- +5.31%
- vs 200-day SMA
- -11.19%
Price ranges
Price & Performance
-7.84 (-13.79%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 45.6% away from all-time highs of $90.04
- PBH is down 21% since the beginning of the year
- PBH is down 20% over the past 12 months
- PBH is up 4% over the past 1 month
- 10% of all PBH investors are betting against PBH
- Number of investors short PBH has gone up 1% versus last month
PBH reads very good: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is -20.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +8.26%
- vs 8-day SMA
- +5.49%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
